Creo Medical Extends Shareholder Offer Deadline - TipRanks
| CREO Stock | 15.63 0.37 2.31% |
Slightly above 61% of Creo Medical's investor base is looking to short. The analysis of overall sentiment of trading Creo Medical Group stock suggests that many investors are alarmed at this time. Creo Medical's investing sentiment can be driven by a variety of factors including economic data, Creo Medical's earnings reports, geopolitical events, and overall market trends.
Creo Medical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Creo daily returns and investor perception about the current price of Creo Medical Group as well as its diversification or hedging effects on your existing portfolios.
Creo |
Creo Medical Extends Shareholder Offer Deadline TipRanks
Read at news.google.com
 |
Creo Medical Fundamental Analysis
We analyze Creo Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creo Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creo Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Creo Medical is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Creo Medical Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Creo Medical stock to make a market-neutral strategy. Peer analysis of Creo Medical could also be used in its relative valuation, which is a method of valuing Creo Medical by comparing valuation metrics with similar companies.
Peers
Creo Medical Related Equities
| 0R15 | SoftBank Group | 2.74 | ||||
| SBID | State Bank | 1.21 | ||||
| AXB | Axis Bank | 1.19 | ||||
| TYT | Toyota | 0.51 | ||||
| RIGD | Reliance Industries | 0.49 | ||||
| GTCO | Guaranty Trust | 0.00 | ||||
| HSBK | Halyk Bank | 1.22 | ||||
| HYUD | Hyundai | 1.82 | ||||
| SMSD | Samsung Electronics | 2.58 | ||||
| SMSN | Samsung Electronics | 3.71 |
Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.